Therapeutic vaccination against Helicobacter pylori infection with recombinant attenuated Salmonella typhimurium urease B snbunit and catalase in mice
- VernacularTitle:重组减毒沙门菌尿素酶B亚单位和过氧化氢酶疫苗治疗幽门螺杆菌感染的实验研究
- Author:
Guoqing LI
;
Minhu CHEN
;
Senlin ZHU
- Publication Type:Journal Article
- Keywords:
Helicobacter pylori;
Urease B subunit;
Catalase;
Vaccine;
Treatment
- From:
Chinese Journal of Digestion
2001;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of oral recombinant attenuated Salmonella ophimurium urease B subunit and catalase in the treatmeat of H.pylori infection in a H.pylori infected mouse model. Methods Thirty C57BL/6 mice were randomized into three groups and challenged twice by oral administration of H.pylori in three days. Four weeks after the second challenge, the mice were immunized by oral administration of recombinant attenuated Salmonella typhimurium urease B subunit (group A), recombinant attenuated Salmonella typhimurium catalase (group B), or saline (group C) respectively, and all mice were sacrificed 4 weeks after the immunization. The stomachs were collected for rapid urease test, modified Giemsa stain and quantitative culture to observe the gastric H.pylori densities, and HE stain was performed to assess the presence of inflammation. Lymph cells from the spleens were served for lymphoproliferation assay. Results Gastric H.pylori densities of group A, B and C were 1.58?10 5 CFU/g, 4.88?10 5 CFU/g and 1.92?10 6CFU/g respectively. H.pylori densities of therapeutic groups were significantly decreased ( P
